建立了一种新型的Cynomolgus子超尿血病模型
Ji-Wei Wang1,2,3, Le Zhang1, Can Yang1
1Department of Pharmaceutical Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Animal models and experimental medicine
|January 20, 2026
概括
研究人员开发了一种新的Cynomolgus子模型,用于慢性高尿血症. 这种模式维持了尿酸水平的升高,有助于研究神经退行性疾病和认知功能.
科学领域:
- 灵长类动物模型
- 代谢性疾病是一种代谢性疾病.
- 神经科学是一个神经科学.
背景情况:
- 慢性高尿血症与痛风和脏疾病有关.
- 尿酸具有潜在的抗氧化和神经保护作用.
- 现有的灵长类模型无法维持长期的高尿血症或模仿受损排泄.
研究的目的:
- 建立一个非人类灵长类模型的慢性高尿血.
- 为了研究尿酸代谢和输送基因表达.
- 促进对高尿路血症在神经退行症中的作用的研究.
主要方法:
- 在Cynomolgus和小鼠中评估尿酶表达.
- 创建了一个使用氧酸盐,甲酸盐和腺的高尿血病模型.
- 分析了对尿酸代谢和转运器基因表达的影响.
主要成果:
- 比起老鼠,Cynomolgus子的尿酶活性较低.
- 该模型通过改变分泌,降解和合成实现了持续的高尿素血.
- 肠/脏尿酸输送基因表达被调节.
结论:
- 一个新的Cynomolgus子高尿血症模型已成功建立.
- 这种模型对于研究高尿素血与神经退行性疾病的联系是有价值的.
- 这将有助于阐明血清尿酸如何影响认知功能.
相关概念视频
Clinically Relevant Drug Product Specifications: Methods of Establishment
208
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
208
Molecular Models
43.6K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
The Bohr Model
80.3K
Following the work of Ernest Rutherford and his colleagues in the early twentieth century, the picture of atoms consisting of tiny dense nuclei surrounded by lighter and even tinier electrons continually moving about the nucleus was well established. This picture was called the planetary model since it pictured the atom as a miniature “solar system” with the electrons orbiting the nucleus like planets orbiting the sun. The simplest atom is hydrogen, consisting of a single proton as the...
80.3K
Stereotype Content Model
15.4K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.4K
Clearance Models: Physiological Models
294
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
294
Clearance Models: Compartment Models
302
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
302


